Not yet recruiting
Idiopathic pulmonary fibrosis
Not yet recruitingRandomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis
Registered drugNo placebo
Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis
Registered drugNo placebo
- Disease:Idiopathic pulmonary fibrosis
- Substances:DeupirfenidonePirfenidone
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Deupirfenidone





